Tag: KDC-MN-154

  • Magnolia Bark (Honokiol/Magnolol)

    Botanical with biphenyl active constituents

    Bark of Magnolia officinalis containing the biphenyl compounds honokiol and magnolol with anxiolytic and sleep-promoting activity through GABAergic mechanisms.

    Abstract

    Magnolia bark (Magnolia officinalis bark) contains the biphenyl compounds honokiol and magnolol as the principal active constituents. Both compounds show GABA-A receptor positive allosteric modulation through binding sites distinct from the benzodiazepine site. Honokiol additionally shows anti-inflammatory and antioxidant activity through NF-kB inhibition and direct radical scavenging. The compound has been studied for anxiety, sleep, and inflammatory conditions.

    FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human or animal consumption. All information is provided for research and educational purposes only.